Connect your AI

IQVIA IQV Total Current Liabilities

Total Current Liabilities at other companies

Thermo Fisher ScientificTMO

$14.62B+11.0%

UnitedHealth GroupUNH

$114.12B+0.6%

Labcorp HoldingsLH

$2.64B+27.9%

CognizantCTSH

$3.52B+3.3%

OracleORCL

$41.76B+27.9%

Veeva SystemsVEEV

$1.7B+16.8%

Other financials

Income statement

Revenue$4.2B+8.4%

Gross profit$1.4B+4.4%

Operating income$514.0M+3.6%

Net income$274.0M+10.0%

EPS (diluted)$1.61+15.0%

Balance sheet

Cash & equivalents$1.9B+11.9%

Total debt$16.1B+10.7%

Total equity$6.2B+4.1%

Total assets$29.7B+8.6%

Cash flow

Operating cash flow$618.0M+8.8%

CapEx$127.0M-10.6%

Free cash flow$491.0M+15.3%

Valuation

Market cap$32.25B+26.3%

Enterprise value$46.37B+18.6%

P/E23.3×+2.6×

P/S1.9×+0.3×

Profitability

Gross margin33%-1.7pp

Operating margin13.2%-0.9pp

Net margin8.3%-0.3pp

FCF margin12.7%-1.2pp

Returns & leverage

Return on equity22.7%+1.1pp

Debt / equity2.6×+0.2×

Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is IQVIA's total current liabilities?: IQVIA (IQV) reported total current liabilities of $8.33B in Q1 2026.
How has IQVIA's total current liabilities changed year-over-year?: IQVIA's total current liabilities increased by 16.0% year-over-year, from $7.18B to $8.33B.
What is the long-term trend for IQVIA's total current liabilities?: Over 5 years (2020 to 2025), IQVIA's total current liabilities has grown at a 12.8% compound annual growth rate (CAGR), from $4.56B to $8.34B.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.